Plant-based recombinant butyrylcholinesterase production methods
A new, reliable, easily scalable and reproducible method for the production of recombinant butyrylcholinesterase (rBuChE) is provided. Through the utilization of a plant transfection procedure, various plant strains have been shown to generate effective and scalable amounts of rBuChE under acceptable manufacturing processes to permit reliable levels of such enzymes for desired nerve agent protection requirements (including tetrameric products). As well, such methods in engineered plant lines have shown suitable production of these enzymes in tetramer form with glycan formation and sialylation (for terminal groups) to allow for optimal potency against organophosphorus agent exposure as well as proper immunogenic response within the plant sources. The overall production method, including the transfection and production within mammalian cells, as well as the process steps involved for such a reliable sourcing platform from plants is thus encompassed within the invention.
1. A recombinant butyrylcholinesterase product comprising a butyrylcholinesterase molecule associated with a polyproline adhesion domain permitting butyrylcholinesterase tetramer formation, wherein said recombinant butyrylcholinesterase product exhibits at least 50% sialylation and greater than 50% tetramer formation, the tetramerized product further comprising glycosylation sites and characterized by at least 70% of glycosylation sites being bound to a single terminal sialic acid.
2. The recombinant butyrylcholinesterase product of claim 1 , exhibiting between 50%-73% sialylation, and greater than 50% and up to 75% tetramer formation.
3. The recombinant butyrylcholinesterase product of claim 1 , wherein said recombinant butyrylcholinesterase product exhibits at least 70% sialylation.
4. The recombinant butyrylcholinesterase product of claim 1 , wherein said recombinant butyrylcholinesterase product exhibits at least 60% tetramer formation.
5. The recombinant butyrylcholinesterase product of claim 1 , wherein said recombinant butyrylcholinesterase product is generated from plants or plant cells.
6. The recombinant butyrylcholinesterase product of claim 2 , wherein said recombinant butyrylcholinesterase product is generated from plants or plant cells.
7. The recombinant butyrylcholinesterase product of claim 3 , wherein said recombinant butyrylcholinesterase product is generated from plants or plant cells.
8. The recombinant butyrylcholinesterase product of claim 4 , wherein said recombinant butyrylcholinesterase product is generated from plants or plant cells.
9. A method for production of recombinant butyrycholinesterase from a plant or plant cell, said method comprising the following steps:
a) providing to said plant or plant cell at least one vector capable of expressing said butyrylcholinesterase;
b) incubating said plant or plant cell at conditions that cause the synthesis of said butyrylcholinesterase and including the generation of sialylated glycans and tetramer formation of said butyrylcholinesterase permitting formation of a butyrylcholinesterase product exhibiting sialylation and tetramer formation, wherein the at least one vector capable of expressing said butyrylcholinesterase comprises first and second nucleotide sequences, the first nucleotide sequence encodes a butyrylcholinesterase molecule covalently linked to a signal peptide and the second nucleotide sequence encodes a signal peptide covalently linked a polyproline adhesion domain permitting butyrylcholinesterase tetramer formation; and
c) isolating said butyrylcholinesterase product of step “b” from said plant or plant cell.
10. The method of claim 9 , wherein said butyrylcholinesterase product exhibits at least 50% sialylation and greater than 50% tetramer formation.
11. The method of claim 10 , wherein said butyrylcholinesterase product exhibits between 50%-73% sialylation and greater than 50% and up to 75% tetramer formation.
12. The method of claim 10 , wherein said butyrylcholinesterase product exhibits at least 70% sialylation and at least 60% tetramer formation.
13. A recombinant butyrylcholinesterase product comprising a butyrylcholinesterase molecule associated with a polyproline adhesion domain permitting butyrylcholinesterase tetramer formation, wherein said recombinant butyrylcholinesterase product exhibits at least 50% sialylation and greater than 50% tetramer formation, the tetramerized product further comprising glycosylation sites and characterized by about 70% of glycosylation sites being bound to a single terminal sialic acid.
14. The recombinant butyrylcholinesterase product of claim 13 , exhibiting between 50%-73% sialylation, and greater than 50% and up to 75% tetramer formation.
15. The recombinant butyrylcholinesterase product of claim 13 , wherein said recombinant butyrylcholinesterase product exhibits at least 70% sialylation.
16. The recombinant butyrylcholinesterase product of claim 13 , wherein said recombinant butyrylcholinesterase product exhibits at least 60% tetramer formation.
17. The recombinant butyrylcholinesterase product of claim 13 , wherein said recombinant butyrylcholinesterase product is generated from plants or plant cells.
18. The recombinant butyrylcholinesterase product of claim 13 , wherein said recombinant butyrylcholinesterase product is generated from plants or plant cells.
19. The recombinant butyrylcholinesterase product of claim 13 , wherein said recombinant butyrylcholinesterase product is generated from plants or plant cells.
20. The recombinant butyrylcholinesterase product of claim 13 , wherein said recombinant butyrylcholinesterase product is generated from plants or plant cells.